"Venopathy" at work: recasting neointimal hyperplasia in a new light
Alexander S Yevzlin1, Micah R Chan, Yolanda T Becker
1Departments of Medicine and Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wis, USA.
Translational Research : the Journal of Laboratory and Clinical Medicine
|September 30, 2010
Summary
Neointimal hyperplasia (NH) in hemodialysis vascular access, once seen as detrimental, may actually aid access maturation when properly controlled. This review re-evaluates NH
Area of Science:
- Vascular biology
- Surgical anastomosis
- Renal medicine
Background:
- Hemodialysis vascular access involves unique vascular anastomoses.
- Neointimal hyperplasia (NH) is a key factor limiting access longevity.
- Existing understanding of NH requires re-evaluation.
Purpose of the Study:
- To reframe the understanding of neointimal hyperplasia (NH) in hemodialysis vascular access.
- To explore the potentially beneficial role of NH in access maturation.
- To redefine research objectives for hemodialysis access biology.
Main Methods:
- Review of existing literature on vascular anastomosis and NH.
- Analysis of data suggesting a beneficial role for controlled NH.
- Synthesis of current knowledge to propose new research directions.
Main Results:
- NH may be an expected and potentially beneficial response in vascular access.
- Proper control of NH could promote functional access maturation.
- Current research paradigms for NH may be incomplete.
Conclusions:
- NH's role in hemodialysis vascular access may be more complex than previously thought.
- Further research is needed to understand and harness NH for improved access outcomes.
- A revised understanding of NH is crucial for advancing hemodialysis access interventions.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...